Ovid Therapeutics Inc. 4
4 · Ovid Therapeutics Inc. · Filed May 10, 2017
Insider Transaction Report
Form 4
Daly Timothy
VP, Finance & Corp. Controller
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-05-10+46,510→ 46,510 totalExercise: $8.50From: 2017-05-10Exp: 2027-01-19→ Common Stock (46,510 underlying)
Footnotes (1)
- [F1]100% of the shares subject to the Stock Option vested and became exercisable upon the closing of the initial public offering resulting in gross proceeds to the Issuer of $75,000,000 in accordance with its terms.